AM

Apotheek Molenveld

BE0424.329.567

Gross margin
€ 246K ↓ 7% 2025 Total € 2.94M
Profit
€ 125K ↓ 21% 2025 Total € 1.03M
EBITDA
€ 195K ↓ 16% 2025 Total € 1.74M
EBIT
€ 178K ↓ 20% 2025 Total € 1.45M
Net profit
€ 125K ↓ 21% 2025 Total € 1.03M
Capex
€ 51K ↑ 131% 2025 Total € 241K
Assets
€ 457K ↓ 27% 2025
Equity
€ 143K 2025
Debt
€ 314K ↓ 35% 2025
Cash
€ 34K ↑ 18% 2025
Cashflow
€ 142K ↓ 16% 2025 Total € 1.33M
Working capital
€ 84K ↓ 27% 2025
Current ratio
1.30 ↑ 4% 2025
Quick ratio
0.64 ↓ 25% 2025
Working capital ratio
1.30 ↑ 3% 2025
Debt
€ 314K ↓ 35% 2025
Short-term debt
€ 282K ↓ 38% 2025
Long-term debt
€ 32K ↑ 7% 2025
Debt / EBITDA
1.61 ↓ 23% 2025
Solvability
31.2% ↑ 8.5 pt 2025
Long term debt ratio
0.23 ↑ 10% 2025
Gross profitability
99.7% ↓ 18.5 pt 2025
Net profitability
87.9% ↓ 24 pt 2025
Return On Assets (ROA)
27.44 ↑ 8% 2025
Return On Equity (ROE)
87.86 ↓ 21% 2025
Taxes
€ 24K ↑ 57% 2025 Total € 84K
Salaries and Social Security Contributions
€ 12K ↑ 135% 2025 Total € 140K
Employees
1.60 ↑ 167% 2025
Staff cost per employee
€ 7K ↓ 12% 2025
Dividends
€ 125K ↓ 21% 2025 Total € 977K
Dividend payout
100.0% 2025